论文部分内容阅读
输血后肝炎在平时仍是使用血液或血制品治疗的重要并发症之一。人们可以设想,在战时这种有害影响将更增加。统计表明输血后肝炎占肝炎住院患者的6～8％,其死亡率为5～15％,高于其他病毒性肝炎患者。
Post-transfusion hepatitis is still one of the most important complications of the use of blood or blood products. One can imagine that this detrimental impact will be even greater during wartime. Statistics show that transfusion hepatitis accounts for 6 to 8% of hospitalized patients with hepatitis, the mortality rate is 5 to 15%, higher than other viral hepatitis patients.